en

PRODUCT DETAIL

Deferasirox Mylan 180 mg filmom obalené tablety

Code 2628D
MA number EU/1/19/1386/007
Product Form: tbl flm 30x1x180 mg (blis.PVC/PVDC/Al-jednotk.dávka)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 19 - ANTIDOTA, DETOXICANTIA
ATC:
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AC Iron chelating agents
V03AC03 Deferasirox
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 26.09.2019
Validity: 26.09.2024
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 13.09.2021
eu-flag.png sk-flag.png